Gene · 5817
Papers4,420
Newest first. Swiss-Prot's references are curated; PubTator's text mining finds papers that name the gene, not always ones about it.
281 to 300 of 4,420
Download this page as JSON| Title | Journal | Year | PMID | Found by | Source |
|---|---|---|---|---|---|
| Correction: Prognostic impact of nectin-like molecule-5 (CD155) expression in non-small cell lung cancer. | J Transl Med | 2025 | 40611178 | PubTator, text mining | PubMed |
| Inhibitory Immune Checkpoints beyond Programmed Cell Death Ligand 1 in Merkel Cell Carcinoma: Abundant Expression of TIGIT Independent of the Presence of Merkel Cell Polyoma Virus. | Acta Derm Venereol | 2025 | 40590417 | PubTator, text mining | PubMed |
| Attenuated immune surveillance during squamous cell transformation of pancreatic adenosquamous cancer defines new therapeutic opportunity for cancer interception. | J Immunother Cancer | 2025 | 40550564 | PubTator, text mining | PubMed |
| An Online Family Literacy and Wellness Program for Latino Dual Language Learners: Pilot Randomized Waitlist Controlled Trial. | JMIR Pediatr Parent | 2025 | 40537092 | PubTator, text mining | PubMed |
| Integrated pan-cancer analysis of ADM's role in prognosis, immune modulation and resistance. | Front Immunol | 2025 | 40529377 | PubTator, text mining | PubMed |
| The dual role of TIGIT in regulatory and effector T cells in chronic liver disease. | JHEP Rep | 2025 | 40496440 | PubTator, text mining | PubMed |
| A Novel Class of Multi-substituted Diaryl Scaffold Derivatives Inhibit Glioblastoma Progression by Targeting CD155. | Adv Sci (Weinh) | 2025 | 40492418 | PubTator, text mining | PubMed |
| Effects of ibrutinib and venetoclax on the expression of immune checkpoint molecules in leukemic blasts of patients with acute lymphoblastic leukemia. | Biochem Biophys Rep | 2025 | 40469777 | PubTator, text mining | PubMed |
| Pan-cancer analysis identifies CD155 as a promising target for CAR-T cell therapy. | Genome Med | 2025 | 40457441 | PubTator, text mining | PubMed |
| Acute mountain sickness prediction: a concerto of multidimensional phenotypic data and machine learning strategies in the framework of predictive, preventive, and personalized medicine. | EPMA J | 2025 | 40438497 | PubTator, text mining | PubMed |
| Phenotyping vasodilator responsiveness in idiopathic pulmonary arterial hypertension: any role for the cardiopulmonary exercise test? | ERJ Open Res | 2025 | 40432822 | PubTator, text mining | PubMed |
| Investigation of TIGIT, PVRIG, CD112 and CD155 expression in early and late onset preeclampsia. | J Mol Histol | 2025 | 40425968 | PubTator, text mining | PubMed |
| CD155 as a prognostic and predictive biomarker in acute myeloid leukemia. | Discov Oncol | 2025 | 40411696 | PubTator, text mining | PubMed |
| Synthetic Biology-Based Engineering Cells for Drug Delivery. | Exploration (Beijing) | 2025 | 40395752 | PubTator, text mining | PubMed |
| TIGIT antibody with PVR competitive ability enhances cancer immunotherapy and capable of eliciting anti-tumour immune memory. | Br J Cancer | 2025 | 40394151 | PubTator, text mining | PubMed |
| NECTIN4 regulates the cell surface expression of CD155 in non-small cell lung cancer cells and induces tumor resistance to PD-1 inhibitors. | Cancer Immunol Immunother | 2025 | 40392373 | PubTator, text mining | PubMed |
| scRNA-seq reveals chemotherapy-induced tumor microenvironment changes in pancreatic ductal adenocarcinoma. | Transl Cancer Res | 2025 | 40386264 | PubTator, text mining | PubMed |
| MCSP+ metastasis founder cells activate immunosuppression early in human melanoma metastatic colonization. | Nat Cancer | 2025 | 40379833 | PubTator, text mining | PubMed |
| Unlocking the potential of TIGIT in enhancing therapeutic strategies for acute myeloid leukemia through combined azacitidine therapy. | NPJ Precis Oncol | 2025 | 40374899 | PubTator, text mining | PubMed |
| TIGIT deficiency promotes autoreactive CD4+ T-cell responses through a metabolic‒epigenetic mechanism in autoimmune myositis. | Nat Commun | 2025 | 40374622 | PubTator, text mining | PubMed |
gene-search-2026-11-11-0.2.0
Sources 12
- ClinicalTrials.gov's posted results, through CTTI's AACTFreely available. Acknowledgement requested
- ChEMBL, through Open TargetsCC BY-SA 3.0
- ClinicalTrials.govNo license stated
- EMBL-EBI's patent proteinsNo added restrictions. Attribution expected
- GenBank's patent filesNo restrictions from NCBI. Submitters may hold rights
- HGNCCC0
- NCBI GenePublic domain (US government)
- NIH's project files and grant-paper linksPublic domain
- Open TargetsCC0 1.0
- PubMedNLM's terms
- PubTator 3Public domain
- UniProtCC BY 4.0
Each source's terms
- ClinicalTrials.gov's posted results, through CTTI's AACTClinicalTrials.gov data via Aggregate Analysis of ClinicalTrials.gov (AACT), CTTI. CTTI makes its materials freely available and requests acknowledgement. https://aact.ctti-clinicaltrials.org/documentation/299
- ChEMBL, through Open TargetsCC BY-SA 3.0, for the parts from ChEMBL. Read on 8 Nov 2026 at https://platform-docs.opentargets.org/licence
- ClinicalTrials.govnone stated
- EMBL-EBI's patent proteinsEMBL-EBI's patent protein files from the EPO, JPO, KIPO and USPTO. EMBL-EBI: "EMBL-EBI itself places no additional restrictions on the use or redistribution of the data available via its Data Resources and Tools other than those provided by the original data owners" and "EMBL-EBI expects attribution (e.g. in publications, services or products) for the use of any of its Data Resources and Tools." Read on 11 Nov 2026 at https://www.ebi.ac.uk/about/terms-of-use
- GenBank's patent filesGenBank's patent files. NCBI: "NCBI places no restrictions on the use or distribution of the GenBank data. However, some submitters may claim patent, copyright, or other intellectual property rights in all or a portion of the data they have submitted." Read on 11 Nov 2026 at https://www.ncbi.nlm.nih.gov/genbank/about/
- HGNCCC0: https://www.genenames.org/about/license/
- NCBI GeneNone named for the file. NCBI says information created by or for the US government on its site is in the public domain, and asks that NLM be acknowledged: https://www.ncbi.nlm.nih.gov/home/about/policies/
- NIH's project files and grant-paper linksPublic domain (NIH RePORTER)
- Open TargetsCC0 1.0. Open Targets asks that users cite its latest paper: Buniello et al. 2025, Open Targets Platform: facilitating therapeutic hypotheses building in drug discovery, Nucleic Acids Research 53(D1):D1467, PMID 39657122. Read on 8 Nov 2026 at https://platform-docs.opentargets.org/licence
- PubMedNLM's terms
- PubTator 3Public domain
- UniProtCC BY 4.0. UniProt's licence file: "All databases and documents in the UniProt FTP directory may be copied and redistributed freely, without advance permission, provided that this copyright statement is reproduced with each copy." UniProt asks that users cite its latest paper: The UniProt Consortium, UniProt: the Universal Protein Knowledgebase in 2025, Nucleic Acids Research 53:D609-D617, https://doi.org/10.1093/nar/gkae1010. Read on 9 Nov 2026 at https://www.uniprot.org/help/license
ClinicalTrials.gov's data carry an international copyright outside the United States: https://clinicaltrials.gov/about-site/terms-conditions.
For software
Read this list from software.
Twenty rows a page, as JSON. No key.
GET https://conductscience.org/api/genes/v1/5817/papers?page=15